Literature DB >> 28590151

Characterization of a novel modification of a CHO-produced mAb: Evidence for the presence of tyrosine sulfation.

Jia Zhao1, Jason Saunders2, Svetlana Dukleska Schussler3, Sandra Rios3, Francis Kobina Insaidoo3, Aleksandr L Fridman1, Huijuan Li1, Yan-Hui Liu1.   

Abstract

Herein we describe the investigation of a Chinese hamster ovary (CHO)-expressed human mAb molecule found partially modified by a +80 Da adduct. This mass difference, suggestive of a single sulfation or phosphorylation addition, was observed by mass analysis of the intact and reduced molecule by mass spectrometry (MS). The modification was located on tyrosine 31 (Y31) of the light chain in the complementarity-determining region 1 by liquid chromatography (LC)-MS peptide mapping and electron transfer dissociation fragmentation. The complete loss of the 80 Da modification moiety during collision induced dissociation fragmentation suggested this modification could not be a tyrosine phosphorylation. Treatment of the mAb with alkaline phosphatase confirmed our hypothesis. Western blot experiment using anti-tyrosine sulfation antibody and LC retention time correlation with corresponding synthetic sulfated peptides further confirmed the identification of tyrosine sulfation on the light chain. The unique sequence motif with neighboring acidic amino acids and local secondary structure might play a role to make Y31 a substrate residue for sulfation. This type of modification, to our knowledge, has not been previously reported for CHO-produced human IgG antibodies.

Entities:  

Keywords:  CHO cell; monoclonal antibody (mAb); novel modification; tyrosine sulfation

Year:  2017        PMID: 28590151      PMCID: PMC5540082          DOI: 10.1080/19420862.2017.1332552

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  23 in total

1.  Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1.

Authors:  W S Somers; J Tang; G D Shaw; R T Camphausen
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

2.  Analysis of sulfated peptides using positive electrospray ionization tandem mass spectrometry.

Authors:  J F Nemeth-Cawley; S Karnik; J C Rouse
Journal:  J Mass Spectrom       Date:  2001-12       Impact factor: 1.982

Review 3.  Post-translational modifications in the context of therapeutic proteins.

Authors:  Gary Walsh; Roy Jefferis
Journal:  Nat Biotechnol       Date:  2006-10       Impact factor: 54.908

4.  A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin.

Authors:  A Leppänen; P Mehta; Y B Ouyang; T Ju; J Helin; K L Moore; I van Die; W M Canfield; R P McEver; R D Cummings
Journal:  J Biol Chem       Date:  1999-08-27       Impact factor: 5.157

5.  Kinetics of the inhibition of thrombin by hirudin.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochemistry       Date:  1986-08-12       Impact factor: 3.162

6.  Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.

Authors:  M Farzan; T Mirzabekov; P Kolchinsky; R Wyatt; M Cayabyab; N P Gerard; C Gerard; J Sodroski; H Choe
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.

Authors:  S Hemmerich; C Paavola; A Bloom; S Bhakta; R Freedman; D Grunberger; J Krstenansky; S Lee; D McCarley; M Mulkins; B Wong; J Pease; L Mizoue; T Mirzadegan; I Polsky; K Thompson; T M Handel; K Jarnagin
Journal:  Biochemistry       Date:  1999-10-05       Impact factor: 3.162

8.  Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.

Authors:  Hyeryun Choe; Wenhui Li; Paulette L Wright; Natalya Vasilieva; Miro Venturi; Chih-Chin Huang; Christoph Grundner; Tatyana Dorfman; Michael B Zwick; Liping Wang; Eric S Rosenberg; Peter D Kwong; Dennis R Burton; James E Robinson; Joseph G Sodroski; Michael Farzan
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

9.  PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus.

Authors:  T Pouyani; B Seed
Journal:  Cell       Date:  1995-10-20       Impact factor: 41.582

10.  Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.

Authors:  Juan Xu; Xiyun Deng; Min Tang; Lili Li; Lanbo Xiao; Lifang Yang; Juanfang Zhong; Ann M Bode; Zigang Dong; Yongguang Tao; Ya Cao
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  3 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

2.  Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis.

Authors:  Doreen A Wüstenhagen; Phil Lukas; Christian Müller; Simone A Aubele; Jan-Peter Hildebrandt; Stefan Kubick
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

Review 3.  In silico prediction of post-translational modifications in therapeutic antibodies.

Authors:  Shabdita Vatsa
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.